Men are much less likely to get multiple sclerosis (MS) than women, and one reason is that they are protected by high levels of testosterone. Scientists have now discovered how it works. They have identified a guardian molecule — triggered by testosterone — that appears to protect males from disease. When female mice with disease are treated with this protective molecule, their symptoms were eliminated. The findings could lead to a new therapy for MS.Original Article
You may also like
Pharmaceutical Sales Customer Engagement –...
AstraZeneca’s Polyneuropathy Treatment Recommended...
Designing a Strategic Roadmap for Seamless Product...
AAPS PharmSci 360: LBFs and Tackling Oral Biologic...
CHMP Gives Positive Opinion to Novo Nordisk Hemophilia...
GSK, Cambridge to Partner on R&D for Kidney and...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.